Merck Msd
Adjusted earnings of $1.85 for the third quarter included a 22-cent charge associated to collaboration and licensing agreements with Moderna Inc. and other biotech companies. As we pointed out earlier, the worldwide pandemic has impacted pharmaceutical businesses in a unfavorable way over the first half of the year. Since numerous people today delayed their elective procedures,...